US · Healthcare

ZYUS Life Sciences Corporation (ZLSCF)

Drug Manufacturers - Specialty & Generic

ZYUS Life Sciences Corporation (ZLSCF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ZLSCF

P/E ratio

18.00

ZYUS Life Sciences Corporation (ZLSCF) — FAQ

What is ZLSCF's P/E ratio?

The price-to-earnings (P/E) ratio for ZYUS Life Sciences Corporation (ZLSCF) is 18.00 (data as of 2026-05-23).

Does ZYUS Life Sciences Corporation pay a dividend?

Dividend yield is not available in the current snapshot for ZYUS Life Sciences Corporation (ZLSCF). Check the MyAverix Finance app for the latest dividend data.

What sector is ZYUS Life Sciences Corporation in?

ZYUS Life Sciences Corporation (ZLSCF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is ZLSCF listed on?

ZLSCF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)